The Scientific Research Team at Atalanta Therapeutics conducts cutting-edge research to advance the development of RNA interference therapies for neurodegenerative diseases. By employing a diverse range of scientific expertise—from assay development to molecular biology—the team works collaboratively to identify and validate novel therapeutic targets, optimize RNA-based treatments, and support preclinical studies for innovative drug candidates.
View all